Genmab — December 2015
-
Nordea.
-
Novods spm dækker jo egentlig meget af debatten her på PI i da
-
g
-
Ja..Novod tog de fleste med på en gang.
-
Fantomas....Hvem gør ikke det.
-
KOL'erne kan ikke rigtigt gå imod FDA i deres kommenater - så de vil nok ikke åbne for off-label i en offentlig diskussion
-
Off-label snakken havde vi i fredags på sympositummet. Phillipe Moreau anbefalede helt klart at vente på data som ville komme "soon".
-
peter Aabo har 1200
-
Bowers,
-
PI skal repræsenteres på næste ASH! Hvem vil med?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind